| Literature DB >> 18356813 |
Abstract
Many recombinant growth factors have failed in clinical trials due to off-target effects. We describe a method for circumventing off-target effects that involves equipping cells with a conditionally active signaling protein that can be specifically activated by an exogenously administered synthetic ligand. We believe that this approach will have many applications in gene and cell therapy.Mesh:
Substances:
Year: 2008 PMID: 18356813 DOI: 10.1038/gt.2008.43
Source DB: PubMed Journal: Gene Ther ISSN: 0969-7128 Impact factor: 5.250